Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2003
11/06/2003CA2483072A1 Cannabinoids
11/06/2003CA2454612A1 Ultrasonic doppler effect speed measurement
11/06/2003CA2452176A1 Process for preparing ruthenium-carrying alumina and process for oxidizing alcohol
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0770064B1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/04/2003US6642392 Pyrrole derivatives
11/04/2003US6642273 Dermatology, vision defects, cardiovascular disorders, antiinflammatory
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2096515C Benzo[b]thiophen-3-yl-piperazines, a process for their preparation and their use as medicaments
10/2003
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002019033A3 Photoacid generators and photoresists comprising same
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/30/2003US20030203941 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030201713 Design and synthesis of advanced NLO materials for electro-optic applications
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1244609B1 Preparing method of 2-phenylalkanoic acid derivatives
10/29/2003EP1114025B1 Method for producing derivatives of 4-alkylsulfinyl methylarylene methanols
10/29/2003EP1091952B1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1016660B1 Compounds having 2.2.1]bicyclo skeleton
10/29/2003EP0831822B1 The use of calcium channel antagonists for treating cardiac, renal and gastrointestinal disorders and hypertension
10/29/2003CN1125821C Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
10/28/2003US6639109 Process for production of thioalkylamine derivatives
10/28/2003US6639083 High yield production of 2-thienyl-2-ethanol; alkali metallization of thiophene in presence of electron transfer agent; hydrolysis with ethylene oxide
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638685 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003US20030199702 Process for the preparation of pgd2 antagonist
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199570 Phenyl substituted thiophenes as estrogenic agents
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199508 Compounds and their therapeutic use
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199393 N- ([1,2,4,] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
10/23/2003US20030198889 Sulfonium salt compounds represented by the following general formula (2) wherein R1 and R2 represent each an alkyl group optionally having oxo, or R1 and R2 may be cyclized together to form an alkylene group optionally having oxo group for
10/23/2003US20030198880 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353639A1 Primary intermediates for oxidative coloration of hair
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1125063C Refining process of coarse sulfolane product
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635779 Such as dimethylsilandiylbis-6-(3-methylcyclopentadienyl-(1,2-b)-thiophene)zirconium dichloride and methyl
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003US6635364 Aromatic condensed-ring compound, light emitting device material and light emitting device using the same
10/21/2003CA2115277C Cyclohexenone oxime ethers
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084962A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084947A1 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003051801A8 Synthesis of alpha, beta, beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195359 Quinomethane compounds
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 329